The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / October / Aptamer Tests Face the Validation Challenge
Analytical science Genetics and epigenetics Biochemistry and molecular biology Molecular Pathology

Aptamer Tests Face the Validation Challenge

Clinical adoption will require reproducibility, quality control, and evidence of diagnostic utility

10/06/2026 News 2 min read
  • Full Article
  • Summary
  • Takeaways
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Topic Commentary

Share

3 Topic Commentaries

Aptamer Tests Face the Validation Challenge

Aptamer Tests Face the Validation Challenge

  • Andrew N. Hoofnagle
    Andrew N. Hoofnagle, MD, PhD

    Clinical Chemistry / Laboratory Medicine

    •

    University of Washington, Department of Laboratory Medicine & Pathology

    More concretely, the SomaLogic platform has good precision for almost all of its assays, but what if the platform is precisely measuring noise? Indeed, the influence of related proteins and matrix components has never been properly documented.

    Source
  • Manuel Mayr
    Manuel Mayr, MD, PhD

    Cardiovascular Proteomics

    •

    King’s College London, British Heart Foundation Centre, School of Cardiovascular Medicine and Sciences

    Proof of principle, however, still requires independent validation of protein levels through orthogonal validation techniques and linkage to cis-acting Mendelian randomization that do not have epitope effects. In particular, changes in electric charge caused by amino acid substitution may alter the binding properties of the negatively charged aptamers.

    Source
  • John S. Tsang
    John S. Tsang, PhD

    Systems Immunology / Proteomics Bioinformatics

    •

    National Institute of Allergy and Infectious Diseases, National Institutes of Health

    Firstly, we assess different normalization procedures and point out caveats in which a departure from standard strategies is needed to avoid increasing plate effects, while illustrating these observations with data from a multiplate longitudinal vaccination study.

    Source

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.